HomeCompaniesProfile

64x Bio

Enabling next generation medicines. A comprehensive platform and… 


Company Size

11 - 50 employees

Year Founded

2017


About 64x Bio

The future of medicine is taking shape, but scaling it remains a challenge. Some of the biggest breakthroughs in next generation therapies are being held back by manufacturing constraints. The science is moving fast, but the infrastructure is still catching up.

Our VectorSelect platform is designed to unlock the scale these therapies need to survive. We combine massively parallelized screens with computational insights to engineer high yield cell lines and production technologies — accelerating the manufacturing of advanced therapies from the inside out.

Founders & Key People

Alexis Rovner

Alexis Rovner

Co-founder of 64x Bio

Share This Profile

More Companies

Myria

A marketplace of luxury services for the ultra-wealthy

Gauss

Lower interest rates on existing credit cards

Pelm

Plaid for utilities

BotBuilt

We use robots to build houses.

Railbird

A futures market for events.

Buoyant Aero

Bringing back blimps

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

© Copyright 2025 BEAMSTART. All Rights Reserved.